{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T01:32:03Z","timestamp":1773451923141,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100011338","name":"AstraZeneca","doi-asserted-by":"publisher","award":["SEML-8AMK55"],"award-info":[{"award-number":["SEML-8AMK55"]}],"id":[{"id":"10.13039\/100011338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.pupt.2018.04.002","type":"journal-article","created":{"date-parts":[[2018,4,5]],"date-time":"2018-04-05T23:26:26Z","timestamp":1522970786000},"page":"47-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Effects of fluticasone propionate and budesonide on the expression of immune defense genes in bronchial epithelial cells"],"prefix":"10.1016","volume":"50","author":[{"given":"M.","family":"van den Berge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.R.","family":"Jonker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Miller-Larsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.S.","family":"Postma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.H.","family":"Heijink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2018.04.002_bib1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1513\/pats.200402-018MS","article-title":"Glucocorticoids suppress inflammation but spare innate immune responses in airway epithelium","volume":"1","author":"Schleimer","year":"2004","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.pupt.2018.04.002_bib2","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","article-title":"TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease","volume":"356","author":"Calverley","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pupt.2018.04.002_bib3","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/thoraxjnl-2012-202872","article-title":"Inhaled corticosteroids in COPD and the risk of serious pneumonia","volume":"68","author":"Suissa","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2018.04.002_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archinternmed.2008.550","article-title":"Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis","volume":"169","author":"Singh","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.pupt.2018.04.002_bib5","first-page":"CD010115","article-title":"Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease","volume":"3","author":"Kew","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pupt.2018.04.002_bib6","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1378\/chest.15-0627","article-title":"Discontinuation of inhaled corticosteroids in COPD and the risk reduction of pneumonia","volume":"148","author":"Suissa","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2018.04.002_bib7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00408-017-9990-8","article-title":"Inhaled corticosteroid use and the risk of pneumonia and COPD exacerbations in the UPLIFT study","volume":"195","author":"Morjaria","year":"2017","journal-title":"Lung"},{"key":"10.1016\/j.pupt.2018.04.002_bib8","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0140-6736(09)61250-2","article-title":"Budesonide and the risk of pneumonia: a meta-analysis of individual patient data","volume":"374","author":"Sin","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2018.04.002_bib9","doi-asserted-by":"crossref","first-page":"f3306","DOI":"10.1136\/bmj.f3306","article-title":"Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting beta2 agonist: observational matched cohort study (PATHOS)","volume":"346","author":"Janson","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.pupt.2018.04.002_bib10","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.2147\/COPD.S139035","article-title":"Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist","volume":"12","author":"Yang","year":"2017","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.pupt.2018.04.002_bib11","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.2147\/COPD.S116750","article-title":"The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients' life quality with COPD in Taiwan (IMPACT) study","volume":"11","author":"Wang","year":"2016","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.pupt.2018.04.002_bib12","doi-asserted-by":"crossref","first-page":"1700037","DOI":"10.1183\/13993003.00037-2017","article-title":"The risk of mycobacterial infections associated with inhaled corticosteroid use","volume":"50","author":"Brode","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2018.04.002_bib13","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2147\/COPD.S128358","article-title":"Risk of pneumonia with budesonide-containing treatments in COPD: an individual patient-level pooled analysis of interventional studies","volume":"12","author":"Hollis","year":"2017","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.pupt.2018.04.002_bib14","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.2147\/COPD.S143656","article-title":"Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD","volume":"12","author":"Janson","year":"2017","journal-title":"International J COPD"},{"key":"10.1016\/j.pupt.2018.04.002_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.pupt.2007.08.005","article-title":"Do airway clearance mechanisms influence the local and systemic effects of inhaled corticosteroids?","volume":"21","author":"Edsbacker","year":"2008","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.pupt.2018.04.002_bib16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1465-9921-10-104","article-title":"The bioavailability and airway clearance of the steroid component of budesonide\/formoterol and salmeterol\/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial","volume":"10","author":"Dalby","year":"2009","journal-title":"Respir. Res."},{"key":"10.1016\/j.pupt.2018.04.002_bib17","first-page":"623","article-title":"Reversible fatty acid conjugation of budesonide. Novel mechanism for prolonged retention of topically applied steroid in airway tissue","volume":"26","author":"Miller-Larsson","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.pupt.2018.04.002_bib18","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1183\/09031936.97.10092139","article-title":"Airway epithelium as an effector of inflammation: molecular regulation of secondary mediators","volume":"10","author":"Martin","year":"1997","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2018.04.002_bib19","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0091-6749(98)70008-9","article-title":"Epithelia cells as regulators of airway inflammation","volume":"102","author":"Polito","year":"1998","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.pupt.2018.04.002_bib20","doi-asserted-by":"crossref","first-page":"7678","DOI":"10.4049\/jimmunol.178.12.7678","article-title":"Down-regulation of E-cadherin in human bronchial epithelial cells leads to epidermal growth factor receptor-dependent Th2 cell-promoting activity","volume":"178","author":"Heijink","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.pupt.2018.04.002_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1165\/rcmb.2008-0449OC","article-title":"House dust mite-promoted epithelial-to-mesenchymal transition in human bronchial epithelium","volume":"42","author":"Heijink","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.pupt.2018.04.002_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/ACI.0000000000000346","article-title":"Asthma guidelines: the Global Initiative for Asthma in relation to national guidelines","volume":"17","author":"Becker","year":"2017","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.pupt.2018.04.002_bib23","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0039-128X(94)90054-X","article-title":"Binding kinetics of fluticasone propionate to the human glucocorticoid receptor","volume":"59","author":"Hogger","year":"1994","journal-title":"Steroids"},{"key":"10.1016\/j.pupt.2018.04.002_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1164\/ajrccm.162.1.9901006","article-title":"Transcriptional potencies of inhaled glucocorticoids","volume":"162","author":"Jaffuel","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2018.04.002_bib25","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jaci.2013.05.028","article-title":"Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor kappaB and c-Jun N-terminal kinase activation","volume":"132","author":"Papi","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.pupt.2018.04.002_bib26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0091-6749(98)70388-4","article-title":"Prostaglandin E2 differentially modulates IL-5 gene expression in activated human T lymphocytes depending on the costimulatory signal","volume":"101","author":"Borger","year":"1998","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.pupt.2018.04.002_bib27","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1165\/rcmb.2006-0160OC","article-title":"Der p, IL-4, and TGF-beta cooperatively induce EGFR-dependent TARC expression in airway epithelium","volume":"36","author":"Heijink","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.pupt.2018.04.002_bib28","doi-asserted-by":"crossref","first-page":"e94010","DOI":"10.1371\/journal.pone.0094010","article-title":"Rhinovirus-16 induced release of IP-10 and IL-8 is augmented by Th2 cytokines in a pediatric bronchial epithelial cell model","volume":"9","author":"Cakebread","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pupt.2018.04.002_bib29","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1038\/sj.leu.2403516","article-title":"Identification of novel direct transcriptional targets of glucocorticoid receptor","volume":"18","author":"U M","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.pupt.2018.04.002_bib30","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/417552a","article-title":"A component of innate immunity prevents bacterial biofilm development","volume":"417","author":"Singh","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.pupt.2018.04.002_bib31","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.biocel.2010.01.021","article-title":"Human beta-defensin 1: a restless warrior against allergies, infections and cancer","volume":"42","author":"Prado-Montes de Oca","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.pupt.2018.04.002_bib32","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1128\/CMR.00014-10","article-title":"The airway epithelium: soldier in the fight against respiratory viruses","volume":"24","author":"Vareille","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.pupt.2018.04.002_bib33","doi-asserted-by":"crossref","first-page":"9541","DOI":"10.1073\/pnas.95.16.9541","article-title":"The peptide antibiotic LL-37\/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface","volume":"95","author":"Bals","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pupt.2018.04.002_bib34","doi-asserted-by":"crossref","first-page":"L53","DOI":"10.1152\/ajplung.00357.2004","article-title":"Exposure to TARC alters beta2-adrenergic receptor signaling in human peripheral blood T lymphocytes","volume":"289","author":"Heijink","year":"2005","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.pupt.2018.04.002_bib35","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1164\/rccm.200801-136OC","article-title":"Rhinovirus disrupts the barrier function of polarized airway epithelial cells","volume":"178","author":"Sajjan","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2018.04.002_bib36","doi-asserted-by":"crossref","first-page":"12273","DOI":"10.1128\/JVI.79.19.12273-12279.2005","article-title":"Toll-like receptor 3 is induced by and mediates antiviral activity against rhinovirus infection of human bronchial epithelial cells","volume":"79","author":"Hewson","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.pupt.2018.04.002_bib37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cellimm.2009.09.008","article-title":"Toll-like receptor 3 is involved in airway epithelial cell response to non typeable Haemophilus influenzae","volume":"260","author":"Teng","year":"2010","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.pupt.2018.04.002_bib38","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1440-1843.2012.02200.x","article-title":"Innate immunity to influenza in chronic airways diseases","volume":"17","author":"Hsu","year":"2012","journal-title":"Respirology"},{"key":"10.1016\/j.pupt.2018.04.002_bib39","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1183\/09031936.00209513","article-title":"Glucocorticoids induce the production of the chemoattractant CCL20 in airway epithelium","volume":"44","author":"Zijlstra","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2018.04.002_bib40","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jaci.2006.10.005","article-title":"Macrophage inflammatory protein 3alpha deficiency in atopic dermatitis skin and role in innate immune response to vaccinia virus","volume":"119","author":"Kim","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.pupt.2018.04.002_bib41","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/jlb.66.4.549","article-title":"S100A8: emerging functions and regulation","volume":"66","author":"Passey","year":"1999","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.pupt.2018.04.002_bib42","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2174\/187152309789838975","article-title":"Anti-infective protective properties of S100 calgranulins","volume":"8","author":"Hsu","year":"2009","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"10.1016\/j.pupt.2018.04.002_bib43","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1183\/09031936.97.10102327","article-title":"Iron-binding proteins in sputum of chronic bronchitis patients with Haemophilus influenzae infections","volume":"10","author":"Vogel","year":"1997","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2018.04.002_bib44","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.arcmed.2012.08.008","article-title":"Immune response to seasonal influenza a virus infection: a proteomic approach","volume":"43","author":"Teran","year":"2012","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.pupt.2018.04.002_bib45","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60968-9","article-title":"Chronic obstructive pulmonary disease","volume":"379","author":"Decramer","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2018.04.002_bib46","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1183\/09031936.00065809","article-title":"Characterisation of cell adhesion in airway epithelial cell types using electric cell-substrate impedance sensing","volume":"35","author":"Heijink","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2018.04.002_bib47","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/jam.2000.13.281","article-title":"Formulation of inhaled medicines: effect of delivery vehicle on immortalized epithelial cells","volume":"13","author":"Forbes","year":"2000","journal-title":"J. Aerosol Med."},{"issue":"3","key":"10.1016\/j.pupt.2018.04.002_bib48","first-page":"A407","article-title":"Sorption of lipophilic glucocorticoids to plastics may interfere with determinations of their activity","volume":"153","author":"Wieslander","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.pupt.2018.04.002_bib49","first-page":"19","article-title":"Solubility of fluticasone propionate in aqueous solutions measured by a method avoiding its adsorption to experimental tools","volume":"4","author":"Tokumura","year":"2014","journal-title":"Int. Res. J. Pharmaceut. Appl. Sci."},{"key":"10.1016\/j.pupt.2018.04.002_bib50","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12931-015-0318-z","article-title":"Budesonide and fluticasone propionate differentially affect the airway epithelial barrier","volume":"17","author":"Heijink","year":"2016","journal-title":"Respir. Res."},{"key":"10.1016\/j.pupt.2018.04.002_bib51","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1034\/j.1398-9995.1999.00087.x","article-title":"Fluticasone and budesonide inhibit cytokine release in human lung epithelial cells and alveolar macrophages","volume":"54","author":"Ek","year":"1999","journal-title":"Allergy"},{"key":"10.1016\/j.pupt.2018.04.002_bib52","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1165\/ajrcmb.20.4.3265","article-title":"Inhibition of VCAM-1 expression in human bronchial epithelial cells by glucocorticoids","volume":"20","author":"Atsuta","year":"1999","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"Pt 2","key":"10.1016\/j.pupt.2018.04.002_bib53","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1042\/bj3280707","article-title":"Induction of the E-selectin promoter by interleukin 1 and tumour necrosis factor alpha, and inhibition by glucocorticoids","volume":"328","author":"Ray","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.pupt.2018.04.002_bib54","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/sj.bjp.0702613","article-title":"Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-kappaB and lack of I-kappaB involvement","volume":"127","author":"Adcock","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pupt.2018.04.002_bib55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2125.2008.03164.x","article-title":"Evidence of the in vivo esterification of budesonide in human airways","volume":"66","author":"van den Brink","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.pupt.2018.04.002_bib56","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1183\/09031936.97.10071496","article-title":"Distribution of inhaled fluticasone propionate between human lung tissue and serum in vivo","volume":"10","author":"Esmailpour","year":"1997","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2018.04.002_bib57","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/bdd.2510140511","article-title":"Relationship between lung tissue and blood plasma concentrations of inhaled budesonide","volume":"14","author":"Van den Bosch","year":"1993","journal-title":"Biopharm Drug Dispos."},{"key":"10.1016\/j.pupt.2018.04.002_bib58","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/bph.13014","article-title":"An analysis of glucocorticoid receptor-mediated gene expression in BEAS-2B human airway epithelial cells identifies distinct, ligand-directed, transcription profiles with implications for asthma therapeutics","volume":"172","author":"Joshi","year":"2015","journal-title":"Br. J. Pharmacol."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553917303097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553917303097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T13:51:21Z","timestamp":1534945881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553917303097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":58,"alternative-id":["S1094553917303097"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2018.04.002","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of fluticasone propionate and budesonide on the expression of immune defense genes in bronchial epithelial cells","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2018.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}